P3 Health reaffirms 2023 guidance; 2024 revenue $1.45B-$1.55B, positive EBITDA $20M-$40M

P3 Health Partners Inc.

2023-FY EPS reported -$0.63 revenue$1,266,375,000

FY2023 reaffirmed: revenue $1.2B-$1.25B, medical margin $155M-$175M, Adj. EBITDA loss $30M-$50M.
FY2024 guidance: revenue $1.45B-$1.55B, medical margin $230M-$250M, Adj. EBITDA positive $20M-$40M.
Medicare Advantage members expected 125k-135k in 2024, up from 115k-120k in 2023.
Medical margin PMPM guided $165-$175 in 2024, up from $120-$130 in 2023.
Management expects meaningful profitability in 2024, citing robust pipeline and managed cost trend.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

P3 Health Partners Inc. reported Full-Year 2024 results: revenue $1.45 billion to $1.55 billion. Guidance initiated.

Period: Full-Year 2024
Revenue: $1.45 billion to $1.55 billion
Guidance: initiated
Result: guidance update

Exact text from the filing

Providing full-year 2024 guidance: • Medicare Advantage Members from 125,000 to 135,000 • Revenue from $1.45 billion to $1.55 billion • Medical Margin from $230 million to $250 million • Medical Margin PMPM from $165 to $175 • Adjusted EBITDA from $20 million to $40 million, as previously announced

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

P3 Health Partners Inc. reported Full-Year 2023 results: revenue $1.2 billion to $1.25 billion. Guidance reaffirmed.

Period: Full-Year 2023
Revenue: $1.2 billion to $1.25 billion
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Reaffirming full-year 2023 guidance : • Medicare Advantage Members from 115,000 to 120,000 • Revenue from $1.2 billion to $1.25 billion • Medical Margin from $155 million to $175 million • Medical Margin PMPM from $120 to $130 • Adjusted EBITDA is expected to be a loss between $50 million and $30 million

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-000993

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.